検索結果 - "Bristol Myers Squibb"

A comparative study of pharmacokinetics and bioequivalence of Cardiopril tablets 20 mg (JSC «Himfarm», Kazakhstan) and Monopril® tablets of 20 mg («Bristol-Myers Squibb SRL», Italy) 著者: A. K. Sariev, D. A. Abaimov, M. V. Tankevich, S. A. Altinbekov, G. A. Dzholdygulov, V. N. Seryakov, Y. . Budach, O. . Kurilov

Connect to this object online.

Population Pharmacokinetics of CC-122 著者: Cheng Y, Chen J, Pourdehnad M, Zhou S, Li Y

Connect to this object online.

A Phase 1, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics of Iberdomide in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared with Healthy Subjects 著者: Cheng Y, Ye Y, Gaudy A, Ghosh A, Xue Y, Wang A, Zhou S, Li Y

Connect to this object online.

Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes 著者: Gibson EJ, Begum N, Koblbauer I, Dranitsaris G, Liew D, McEwan P, Tahami Monfared AA, Yuan Y, Juarez-Garcia A, Tyas D, Lees M

Connect to this object online.

Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects 著者: Frost C, Shenker A, Jhee S, Yu Z, Wang J, Bragat A, Pursley J, LaCreta F

Connect to this object online.

Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure–response analysis of a Phase III study 著者: Wang X, Roy A, Hochhaus A, Kantarjian HM, Chen TT, Shah NP

Connect to this object online.

Retrospective analysis of drug utilization, health care resource use, and costs associated with IFN therapy for adjuvant treatment of malignant melanoma 著者: Zhang Y, Le TK, Shaw JW, Kotapati S

Connect to this object online.

The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects 著者: Frost C, Song Y, Yu Z, Wang J, Lee LS, Schuster A, Pollack A, LaCreta F

Connect to this object online.

Costs and Cost Drivers Associated with Non-Small-Cell Lung Cancer Patients Who Received Two or More Lines of Therapy in Europe 著者: Verleger K, Penrod JR, Manley Daumont M, Solem C, Luo L, Macahilig C, Hertel N

Connect to this object online.

Relative value assessment: characterizing the benefit of oncology therapies through diverse survival metrics from a US perspective 著者: Macaulay R, Ahuja A, Ademisoye E, Juarez-Garcia A, Shaw JW

Connect to this object online.

A Cost per Responder Model for Abatacept versus Adalimumab Among Rheumatoid Arthritis Patients with Seropositivity 著者: Park SH, Han X, Lobo F, Nanji S, Patel D

Connect to this object online.

Recommendations from a Dialogue on Evolving National Cancer Institute-Designated Comprehensive Cancer Center Community Outreach and Engagement Requirements: A Path Forward

Connect to this object online.

Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor 著者: Upreti VV, Song Y, Wang J, Byon W, Boyd RA, Pursley JM, LaCreta F, Frost CE

Connect to this object online.

Impact of early intervention and disease modification in patients with predementia Alzheimer’s disease: a Markov model simulation 著者: Budd D, Burns LC, Guo Z, L’Italien G, Lapuerta P

Connect to this object online.

Systematic literature review of treatment patterns for venous thromboembolism patients during transitions from inpatient to post-discharge settings 著者: Trocio J, Rosen VM, Gupta A, Dina O, Vo L, Hlavacek P, Rosenblatt L

Connect to this object online.

Systematic Literature Review of Real-World Evidence on Dose Escalation and Treatment Switching in Ulcerative Colitis 著者: Singh H, Wilson L, Tencer T, Kumar J

Connect to this object online.

Neugebauer: "Aus unserer Sicht innovationsfeindlich" 著者: Peter Stegmaier

Connect to this object online.

Epidemiology, patient profile, and health care resource use for hepatitis C in Italy 著者: Sangiorgi D, Perrone V, Buda S, Boglione L, Cariti G, Lefevre C, Nappi C, Degli Esposti L

Connect to this object online.

Relatlimab: a novel drug targeting immune checkpoint LAG-3 in melanoma therapy 著者: Jingjing Su, Yiting Fu, Zitong Cui, Zain Abidin, Jingsong Yuan, Xinmiao Zhang, Runmin Li, Chunzhen Zhao

Connect to this object online.

Economic Evaluation of Single versus Combination Immuno-Oncology Therapies: Application of a Novel Modelling Approach in Metastatic Melanoma 著者: Gibson EJ, Begum N, Koblbauer I, Dranitsaris G, Liew D, McEwan P, Yuan Y, Juarez-Garcia A, Tyas D, Pritchard C

Connect to this object online.